Proteostasis Therapeutics Inc operates in the healthcare sector of United States. Its business involves the discovery and development of therapeutics to correct the imbalance of the protein biosynthesis process.
Stock Price Prediction
Update at 5:00pm EST
1.101 - 1.105
1.105 - 1.11
1.049 - 1.053
1.053 - 1.058
1.081 - 1.089
1.089 - 1.097
as of: 2019-11-19 4:29:15 PM
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.PTI has closed below upper band by 19.6%. Bollinger Bands are 110.8% wider than normal. The large width of the bands suggest high volatility as compared to PTI's normal range. The bands have been in this wide range for 5 bars. This is a sign that the current trend might continue.
2019-11-11 Navigator diz não haver justificação para a greve marcada de 13 a 16 de novembro A The Navigator Company considera não haver justificação para a greve que os trabalhadores pretendem realizar entre os dias 13 e 16 de novembro, tendo em conta a redução de horários de trabalho e aumentos remuneratórios registados.
2019-10-29 Proteostasis Therapeutics (PTI) May Report Negative Earnings: Know the Trend Ahead of Q3 Release Proteostasis (PTI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.